Prediction of improvement of cerebral perfusion with I-123 iomazenil SPECT

Ann Nucl Med. 1999 Aug;13(4):265-8. doi: 10.1007/BF03164903.

Abstract

We report a case of 61-year old man who was suffering from cerebrovascular disease with right hemiparesis and received I-123 iomazenil (IMZ) SPECT prior to carotid endoarterectomy. Severe stenosis of the right internal carotid artery and occlusion of the left middle cerebral artery (MCA) were revealed by cerebral angiography, and a hypoperfused area in left MCA territory and crossed cerebellar diaschisis (CCD) on I-123 IMP SPECT was demonstrated. In contrast, IMZ SPECT showed symmetric normal distribution. After the carotid endoarterectomy, the hypoperfused area in left MCA territory on IMP SPECT and hemiparesis had improved. It is thought that IMZ SPECT can be a useful tool for the prediction of improvement of cerebral perfusion and the clinical outcome.

MeSH terms

  • Arterial Occlusive Diseases / diagnostic imaging*
  • Arterial Occlusive Diseases / surgery
  • Brain / diagnostic imaging*
  • Carotid Artery, Internal
  • Carotid Stenosis / diagnostic imaging*
  • Carotid Stenosis / surgery
  • Cerebral Arterial Diseases / diagnostic imaging*
  • Cerebral Arterial Diseases / surgery
  • Cerebral Infarction / diagnostic imaging*
  • Cerebral Infarction / etiology
  • Cerebral Infarction / surgery
  • Cerebrovascular Circulation*
  • Endarterectomy, Carotid
  • Female
  • Flumazenil / analogs & derivatives*
  • Flumazenil / pharmacokinetics
  • Functional Laterality
  • Humans
  • Iodine Radioisotopes* / pharmacokinetics
  • Male
  • Middle Aged
  • Paresis / etiology
  • Radiopharmaceuticals* / pharmacokinetics
  • Tomography, Emission-Computed, Single-Photon
  • Treatment Outcome

Substances

  • Iodine Radioisotopes
  • Radiopharmaceuticals
  • Flumazenil
  • iomazenil